Literature DB >> 15857187

Knowledge, attitudes, and utilization of BRCA1/2 testing among women with early-onset breast cancer.

Nikki Peters1, Susan M Domchek, Susan M Domcheck, Abigail Rose, Rachael Polis, Jill Stopfer, Katrina Armstrong.   

Abstract

A total of 2,400 questionnaires were mailed to members of two mid-Atlantic breast cancer awareness/support groups to investigate the association between attitudes, knowledge, and use of BRCA1/2 testing among women with early-onset breast cancer. Of the 493 (21%) questionnaires returned, 406 respondents had a diagnosis of breast cancer, of whom 248 were diagnosed prior to age 50 and included in the analyses. Eighty-three percent (206/248) of these women had heard of BRCA1/2 testing and 12.5% (31/248) had undergone BRCA1/2 testing. Among women who had heard of BRCA1/2 testing, women who had been tested were younger (p = 0.03), more likely to have a college education (p = 0.03), more likely to have a family member who had undergone BRCA1/2 testing (p = 0.005), and had greater knowledge, more positive attitudes, and fewer negative attitudes about BRCA1/2 testing (p = 0.02, p = 0.004, and p = 0.004, respectively). In this sample, knowledge regarding BRCA1/2 testing is high, but uptake of genetic testing is low. Lack of information regarding how genetic testing might alter health-care decisions and fear about the genetic testing procedure, its costs, and possible false-positive results are associated with low uptake of genetic testing. Further education regarding these specific points may enhance the use of genetic testing.

Entities:  

Mesh:

Year:  2005        PMID: 15857187     DOI: 10.1089/gte.2005.9.48

Source DB:  PubMed          Journal:  Genet Test        ISSN: 1090-6576


  24 in total

1.  BRCA1 and BRCA2 Mutation Testing in Young Women With Breast Cancer.

Authors:  Shoshana M Rosenberg; Kathryn J Ruddy; Rulla M Tamimi; Shari Gelber; Lidia Schapira; Steven Come; Virginia F Borges; Bryce Larsen; Judy E Garber; Ann H Partridge
Journal:  JAMA Oncol       Date:  2016-06-01       Impact factor: 31.777

2.  Factors associated with an individuals' decision to withdraw from genetic counseling for BRCA1 and BRCA2 genes mutations: are personality traits involved?

Authors:  Anita Caruso; Cristina Vigna; Valentina Bigazzi; Carlo Leone; Gabriella Maggi; Aline Martayan; Fabio M Sega; Francesco Cognetti; Antonella Savarese
Journal:  Fam Cancer       Date:  2011-09       Impact factor: 2.375

3.  Concerns about cancer risk and experiences with genetic testing in a diverse population of patients with breast cancer.

Authors:  Reshma Jagsi; Kent A Griffith; Allison W Kurian; Monica Morrow; Ann S Hamilton; John J Graff; Steven J Katz; Sarah T Hawley
Journal:  J Clin Oncol       Date:  2015-04-06       Impact factor: 44.544

4.  Psychosocial, attitudinal, and demographic correlates of cancer-related germline genetic testing in the 2017 Health Information National Trends Survey.

Authors:  Megan C Roberts; Erin Turbitt; William M P Klein
Journal:  J Community Genet       Date:  2019-02-20

5.  Measuring genetic knowledge: a brief survey instrument for adolescents and adults.

Authors:  S M Fitzgerald-Butt; A Bodine; K M Fry; J Ash; A N Zaidi; V Garg; C A Gerhardt; K L McBride
Journal:  Clin Genet       Date:  2015-06-29       Impact factor: 4.438

6.  Genetic knowledge and attitudes of parents of children with congenital heart defects.

Authors:  Sara M Fitzgerald-Butt; Jennifer Klima; Kelly Kelleher; Deena Chisolm; Kim L McBride
Journal:  Am J Med Genet A       Date:  2014-09-24       Impact factor: 2.802

7.  Bumps along the translational pathway: anticipating uptake of tailored smoking cessation treatment.

Authors:  Alexandra Elizabeth Shields; Mehdi Najafzadeh; Anna Boonin Schachter
Journal:  Per Med       Date:  2013-11-01       Impact factor: 2.512

8.  Discussions about predictive genetic testing for Lynch syndrome: the role of health professionals and families in decisions to decline.

Authors:  Anaita Kanga-Parabia; Clara Gaff; Louisa Flander; Mark Jenkins; Louise A Keogh
Journal:  Fam Cancer       Date:  2018-10       Impact factor: 2.375

9.  Preferences for genetic testing to identify hereditary colorectal cancer: perspectives of high-risk patients, community members, and clinicians.

Authors:  Judith Walsh; Millie Arora; Christina Hosenfeld; Uri Ladabaum; Miriam Kuppermann; Sara J Knight
Journal:  J Cancer Educ       Date:  2012-03       Impact factor: 2.037

10.  Are physician recommendations for BRCA1/2 testing in patients with breast cancer appropriate? A population-based study.

Authors:  Anne Marie McCarthy; Mirar Bristol; Tracey Fredricks; Lache Wilkins; Irene Roelfsema; Kaijun Liao; Judy A Shea; Peter Groeneveld; Susan M Domchek; Katrina Armstrong
Journal:  Cancer       Date:  2013-07-16       Impact factor: 6.860

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.